In 2002, Clusterbusters was formed to take a pro-active role in researching for a cure for cluster headaches and find new and improved treatments.
Shortly thereafter, 6 advocates traveled to Boston and met with the administration of Harvard Medical School and convinced them of the importance of this research and they agreed to undertake the first psychedelic research project at their institution in 40 years.
Following extensive work building an incredible team, designing the scientific study protocol, collaborating on the research and submissions on the safety of the study, fundraising and navigating through the regulatory and legislative process, we embarked upon a journey of discovery.
On Feb 9th, 2004, and agreement was signed to begin research at Harvard University, the clinical study of psilocybin as a viable treatment option providing, replicating results in a lab that had shown efficacious results far better than anything currently available.
The first published results from this groundbreaking clinical study of this treatment appeared in the prestigious medical journal Neurology in June of 2006.
This has been an incredibly long and often frustrating process that included the discovery of BOL-148, starts and stops of every fashion, thousands of people finding relief with various new options and an unending determination to push forward past every obstacle. The growth of Clusterbusters into an active and successful advocacy group for the entire community, built with contributions from hundreds of people over the years that refused to let the words “can’t”, or “no” stop them from helping others.
Along the way we have added some incredibly dedicated advocates, we have lost one of our original research team members, Dr. Andrew Sewell, added extraordinary researchers and headache specialists to our team, overcome those that have tried to stop us and will continue to push forward.
Congratulations and thank you to everyone that has worked so hard for all these years to make this happen.